Fundraising FoxIA Global — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Linnaeus Therapeuticslinnaeustx.cominJan 2023SEC filingmedium confidence
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
BiotechHaddonfield, US
Patrick T. Mooney(Executive Officer)in
BoardJames Demetriades(Director)Todd Thomson(Director)inMichael D. Poisel(Director)Chris Arendt(Director)
Board seatNicholas Iatropoulos· per SEC Form D · $3.1M raise · filed Jan 2023
Co-investorsKairos Venture Investments, LlcKairos Venture Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.